• LAST PRICE
    0.9459
  • TODAY'S CHANGE (%)
    Trending Up0.0854 (9.9245%)
  • Bid / Lots
    0.9142/ 6
  • Ask / Lots
    0.9881/ 6
  • Open / Previous Close
    0.8604 / 0.8605
  • Day Range
    Low 0.8603
    High 1.0500
  • 52 Week Range
    Low 0.7900
    High 4.2000
  • Volume
    98,955
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.8605
TimeVolumeSLGL
09:32 ET8540.8604
09:36 ET5000.9898
09:48 ET9000.97
10:03 ET3090.9892
10:08 ET18750.94
10:10 ET5000.94
10:14 ET1050.9877
10:30 ET1000.94475
10:35 ET22250.9893
10:39 ET4000.945097
10:44 ET22590.98975
10:46 ET16821.01
10:48 ET2670.97005
10:53 ET14410.913025
11:02 ET2500.94
11:27 ET1000.9002
12:00 ET152000.925
12:02 ET100000.9674
12:09 ET127130.9674
12:16 ET60000.9456
03:36 ET11800.9891
03:54 ET8760.9459
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSLGL
Sol Gel Technologies Ltd
24.0M
-0.9x
---
United StatesOCX
OncoCyte Corp
20.9M
-0.9x
---
United StatesONCT
Oncternal Therapeutics Inc
26.0M
-0.6x
---
United StatesLUMO
Lumos Pharma Inc
19.9M
-0.6x
---
United StatesAIM
AIM ImmunoTech Inc
24.2M
-0.8x
---
United StatesBFRG
Bullfrog AI Holdings, Inc.
23.9M
-3.2x
---
As of 2024-04-16

Company Information

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

Contact Information

Headquarters
Golda Meir 7NESS-ZIONA, Israel 7403650
Phone
---
Fax
---

Executives

Executive Chairman of the Board
Moshe Arkin
Chief Executive Officer, Co-Founder, Director
Alon Seri-Levy
Chief Financial Officer
Gilad Mamlok
Vice President - Operations
Itzik Yosef
Vice President - Quality
Nissim Bilman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$24.0M
Revenue (TTM)
$1.6M
Shares Outstanding
27.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.34
EPS
$-1.02
Book Value
$1.39
P/E Ratio
-0.9x
Price/Sales (TTM)
15.4
Price/Cash Flow (TTM)
---
Operating Margin
-1,885.71%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.